TREM2 and Alzheimer disease: In AD pathogenesis, both subsets initially engage in Aβ phagocytosis via TREM2-dependent mechanisms, but persistent Aβ exposure drives their transition toward a pro-inflammatory phenotype, exacerbating tau pathology and synaptic loss (39) (Table 2).